• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Pharma
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Oncology
  • Awards
    • CRO Awards
    • Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Pharma
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Oncology
  • Awards
    • CRO Awards
    • Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

extended-release

visual of neurons under Parkinsons disease
Pharma

Amneal's new Parkinson's drug passes muster with US regulators

As multiple drugmakers race to bring new levodopa-based Parkinson’s treatments to the market, New Jersey’s Amneal has taken home the gold in the U.S.
Fraiser Kansteiner Aug 8, 2024 3:26am
Rovi

Rovi wins FDA nod to make Moderna's COVID shot at Spanish plant

Feb 28, 2024 11:22am
Injection

Teva taps Royalty to bankroll long-acting schizophrenia drug

Nov 13, 2023 11:40am
FDA

FDA shoots down Amneal's Parkinson's med

Jul 5, 2023 11:08am
FDA stop sign

FDA rejects Incyte's Jakafi XR, hurting pipeline hopes: analyst

Mar 24, 2023 11:05am
Teva Pharmaceuticals

Teva takes 2nd long-acting schizophrenia drug into phase 3

Jan 31, 2023 7:10am

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Biotech
    • Fierce Healthcare
    • Fierce Pharma
  • Our Events
    • Life Sciences Events
©2025 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings